Sort
11,323 grants matching “glioblastoma”
Novel functions of D-type and E-type cyclins in normal and in cancer cells
$431,042Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC
$430,949Kwon-Sik Park · University Of Virginia · U01 · FY2020 · CA
Role of MELK in glioblastomas
$430,850Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · NS
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
$430,716Michael D Gunn · Duke University · P01 · FY2019 · CA
Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models
$430,702Jason Parsons · University Of Liverpool · R01 · FY2021 · CA
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer
$430,654Shawn Hingtgen · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
$430,605Jason Huse · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Adaptive EdU Therapy for Brain Tumors
$430,586Eric Dion Laywell · Florida State University · R15 · FY2013 · NS
TROY HTS Compound Screening
$430,566Nhan L Tran · Mayo Clinic Arizona · R01 · FY2017 · NS
GLIOMA INTERACTION WITH THE NEUROGENIC NICHE THROUGH EXTRACELLULAR VESICLES
$430,375Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · R21 · FY2024 · NS
HKLE-seq: an enrichment method for unbiased amplification and next-generation sequencing of all HERV-K and SVA (HKLE) insertion breakpoints genome-wide in human DNA samples
$430,318So Young Ryu · University Of Nevada Reno · R15 · FY2018 · GM
The DNA Damage Response and Tumorigenesis in the Brain
$430,294Peter J McKinnon · St. Jude Children'S Research Hospital · P01 · FY2017 · CA
Engineering and Evaluation of Human L-Methionase for Cancer Therapy
$430,276George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2012 · CA
Preclinical development of WP1066, an effective inhibitor of STAT3 activation for
$430,262Raymond J Budde · Houston Pharmaceuticals, Inc. · R44 · FY2010 · AI
Rare Central Nervous System Cancers Initiative
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Brain Tumor Immunotherapy
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identifying New Glioma-Associated Tumor Suppressors Oncogenes
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
A RIPK2-Targeting Apoptosis-Inducing Small Molecule for the Treatment of Glioblastoma
$429,916Luke Lee Lairson · Scripps Research Institute, The · R01 · FY2023 · NS
Bimodal EGFR signaling in glioblastoma
$429,910Amyn Habib · Ut Southwestern Medical Center · R01 · FY2022 · NS
Role of Src family kinases in endothelial cell biology
$429,861Brian Patrick Eliceiri · La Jolla Inst For Molecular Medicine · R01 · FY2007 · HL
Pharmacological targeting of circadian clock components to treat glioblastoma
$429,833Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2021 · CA
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
$429,640Erwin G Van Meir · University Of Alabama At Birmingham · R01 · FY2024 · NS
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$429,633George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · CA
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$429,633George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · CA
Developing Therapeutic Strategies for Histone H3.3 Mutant Tumors via Rational Targeting of Specific DNA Repair Pathways
$429,583Akash Gunjan · Florida State University · R15 · FY2017 · CA